13551-101 : Karbinal 4 mg/5ml Oral Suspension, Extended Release
NDC: | 13551-101 |
Labeler: | Fsc Laboratories, Inc |
Product Type: | Human Prescription Drug |
Drug Name: | Karbinal ER |
Dosage Form: | Oral Suspension, Extended Release |
Application #: | NDA022556 |
Rev. Date: |
NDC Package Codes:
- 13551-101-01: 2 BOTTLE, PLASTIC IN 1 CARTON (13551‑101‑01) > 30 ML IN 1 BOTTLE, PLASTIC
- 13551-101-05: 480 ML IN 1 BOTTLE, PLASTIC (13551‑101‑05)
Active Ingredients:
- Carbinoxamine Maleate
Dosage Strength:
- 4 mg/5mL
Pharmaceutical Classes:
- Histamine H1 Receptor Antagonists [MoA]
- Histamine-1 Receptor Antagonist [EPC]
Related Products:
Based on records with the same trade name.- 23594-101 Karbinal 4 mg/5ml Oral Suspension, Extended Release by Zylera Pharmaceuticals, LLC
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 13551-004Next: 13551-125 >
Related Discussions:
carbinoxamine maleate
I was given samples of: palgic carbinoxmine maleate to take for allergiesand sinus problems. What are the side affects o... 1 reply
I was given samples of: palgic carbinoxmine maleate to take for allergiesand sinus problems. What are the side affects o... 1 reply
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.